Skip to Content
Søg Menu

Danish and Nordic Lung Cancer Insights – October Update

/ Jan Andreasen / Amanda Feldballe Bernholm
lung cancer-highlightsLungecancer

Lung Cancer Insights: What’s New in the Field – October Update

/ Jan Andreasen / Amanda Feldballe Bernholm
lung cancer-highlightsLungecancer

Machine Learning Estimation of DAS28-ESR from Accelerometery Signal

/ Pawel Mielnik
Artritis

Behov for mere viden om behandling af NSCLC med immunterapi uden driver mutationer

/ Julie Stougaard / Jan Andreasen
NSCLCLungecancer

Epilepsi i Danmark

/ Angelini Pharma
Epilepsi

Lung Cancer Insights: What’s New in the Field

/ Jan Andreasen / Amanda Feldballe Bernholm
lung cancer-highlightsLungecancer

Hvornår indser vi, at vejen frem er proaktiv snarere end reaktiv?

/ Ingeborg Farver-Vestergaard / Anders Løkke Ottesen
KOL

Nyt behandlingsgennembrud for EGFR-muteret lungekræft

/ Seppo W. Langer
NSCLCLungecancer

Safety Checklist for Antirheumatic Drugs

/ Lykke Skaarup / Tue Kragstrup
Reumatoid artritisSpAPsoriasis artritisJAK-hæmmere

AML Insights – July-August Update: What’s New in the Field

/ Amanda Feldballe Bernholm / Jan Andreasen
AML HighlightsAML

Nordic AML Insights – July-August Update

/ Amanda Feldballe Bernholm / Jan Andreasen
AML HighlightsAML

First-Line NSCLC Without Driver Mutations: Practice, Gaps, and Costs

/ Ronny Öhman / Jan Andreasen
NSCLCLungecancer
Hent flere
Back to top